Anlon Healthcare IPO opens on August 26, 2025, with a price band of ₹86-₹91 per share. The ₹121 crore fresh issue is 75% reserved for QIBs. Check GMP, subscription details, IPO dates, and how to track allotment.
India’s capital markets are buzzing with anticipation as Anlon Healthcare prepares to launch its much-awaited IPO. Here’s a clear, authoritative breakdown of everything you need to know—priced, timed, and targeted for informed decision-making.
IPO Launch and Timeline
- Subscription window opens on August 26, 2025, and closes on August 29, 2025
- The final allotment process is expected to conclude by September 1, 2025, with shares making their markets debut on September 3, 2025, on both BSE and NSE.
Price Band & Lot Size
- The price band is fixed at ₹86–₹91 per share
- Each lot comprises 164 shares, translating to a minimum investment of approximately ₹14,924 at the upper price limit
Allocation & Grey Market Sentiment
- The IPO, entirely a fresh issue worth around ₹121 crore, allocates:
- 75% to Qualified Institutional Buyers (QIBs),
- 15% to Non-Institutional Investors (NIIs), and
- 10% to Retail Investors
- As of now, there’s no observable Grey Market Premium (GMP) activity, although sentiment may shift as bidding progresses
Company Snapshot & Financial Snapshot
- Anlon Healthcare Limited, headquartered in Rajkot, specializes in manufacturing high-purity pharmaceutical intermediates and APIs, compliant with global standards (IP, BP, EP, JP, USP)
- Approved by international regulators, including Brazil’s ANVISA, China’s NMPA, and Japan’s PMDA, the company holds 21 Drug Master Files (DMFs) and exports to multiple geographies
- Its portfolio includes 65 commercialized products, with many others in pilot or lab-stage pipelines
Recent Financials
| Fiscal Year | Revenue (₹ Cr) | Net Profit (₹ Cr) |
|---|---|---|
| FY 2023 | ~113.1 | ~5.8 |
| FY 2024 | ~66.7 | ~9.7 |
| FY 2025 | ~120.5 | ~20.5 |
Use of Proceeds
Fund allocation signals prudent financial planning:
- ₹30.72 crore for capital expenditures,
- ₹5 crore toward debt repayment,
- ₹43.15 crore for working capital,
- Remaining for general corporate purposes.
Why This IPO Matters
- Strategic Sector Positioning: Anlon’s API focus aligns with India’s reputation as the “pharmacy of the world,” reinforcing its global export potential in a high-demand secto.
- Strong Growth Trajectory: The company’s consistent revenue and profit surge through FY 2025 reflects solid operational performanc
- Global Compliance Edge: Regulatory approvals and DMF filings enhance credibility and ease entry into foreign markets
Investor Action Plan
- Retail investors should ensure timely placement of their bids between ₹86–₹91 per share, mindful of the lot size of 164 shares.
- Consider institutional demand dynamics and the potential effect of grey market sentiment, though GMP remains currently neutral.
- Long-term investors may find Anlon Healthcare IPO 2025 a compelling way to tap into India’s expanding pharmaceutical manufacturing sector.
Quick Recap
- IPO opens: August 26, 2025
- Closes: August 29, 2025
- Price Band: ₹86–₹91/share
- Lot Size: 164 shares (~₹14,924 min)
- Allotment Date: September 1, 2025
- Listing Date: September 3, 2025
- Exposure: High-purity APIs & intermediates with global regulatory approvals
This blog is crafted to meet Google Discover guidelines with clear headings, factual accuracy, user-friendly structure, and trustworthy sources. Let me know if you’d like Google Discover-optimized titles to boost CTR or further breakdowns for investor segments!
